Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Cysts 1Long Qt Syndrome 3 1Infertility 1Endometriosis 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Danazol × Clear all
NCT01779232 2016-04-27

Danazol Treatment in Endometriosis Women Before IVF

Centre for Endocrinology and Reproductive Medicine, Italy

Phase 4 Completed
150 enrolled
Gynecologic

Long Qt Syndrome 3, Endometriosis, Infertility, Ovarian Cysts

NCT00003946 2013-06-10

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Completed
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡